Expression of carbohydrate antigens in human esophageal squamous cell carcinoma: Prognostic application and its diagnostic implications

Annals of Surgical Oncology

Volumn 14, Issue 2, 2007, Pages 960-967

  Faried, Ahmad ^a,b   Kimura, Hitoshi ^a   Faried, Leri S ^a   Usman, Nurhayat ^b   Miyazaki, Tatsuya ^a   Kato, Hiroyuki ^a   Yazawa, Shin ^a,c   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

^b PADJADJARAN UNIVERSITY   (Indonesia)

^c OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Carbohydrate antigens; ESCC; Esophageal squamous cell carcinoma; Microvessel density; MVD; Prognosis; Sialyl Lea; Sialyl Lex

Indexed keywords

CARBOHYDRATE ANTIGEN; MONOCLONAL ANTIBODY; SIALYL LEWIS X ANTIBODY; SIALYL LEWIS X ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; PROGNOSIS;

AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GANGLIOSIDES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OLIGOSACCHARIDES; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846628515     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9200-z     Document Type: Article

References (22)

1. Day NE, Varghese C. Oesophageal cancer. Cancer Surv 1994; 19-20:43-54.
2. In: Berrino F, Sant M, Verdecchia A (edset al. Survival of Cancer Patients in Europe: The EUROCARE Study. IARC Scientific Publication No. 132 Lyon, France: IARC; 1995.
3. National Comprehensive Cancer Network: esophageal cancer. Clinical practice guidelines in oncology, version 1. 2004. Available at: http://www.nccn.org. Accessed September 14, 2006.
4. Le Pendu J, Marionneau S, Cailleau-Thomas A, et al. ABH and Lewis histo-blood group antigens in cancer. APMIS 2001; 109:9-31.
5. Kim YJ, Varki A. Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J 1997; 14:569-76.
6. Yazawa S, Asao T, Nagamachi Y, Matta KL. Elevated activities of serum a(1-3)-l-fucosyltransferase in human cancer. J Tumor Marker Oncol 1989; 4:355-62.
7. Yazawa S, Nishihara S, Iwasaki H, et al. Genetic and enzymatic evidence for Lewis enzyme expression in Lewis-negative cancer patients. Cancer Res 1995; 55:1473-78.
8. Akamatsu S, Yazawa S, Tachikawa T, et al. Alpha 2 fi 3sialyltransferase associated with the synthesis of CA 19-9 in colorectal tumors. Cancer 1996; 77:1694-700.
9. Makino T, Shimada Y, Maeda M, et al. Carbohydrate antigens as a risk factor for hematogenous recurrence of esophageal squamous cell carcinoma patients. Oncol Rep 2001; 8:981-85.
10. Inoue K, Ozeki Y, Suganuma T, et al. Vascular-endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer 1997; 79:206-13.
11. Kato H, Yoshikawa M, Miyazaki T, et al. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma. Anticancer Res 2002; 22:3977-84.
12. In: Sobin LH, Wittekind C (edsTNM: Classification of Malignant Tumours6 New York: Wiley; 2002.
13. Faried A, Sohda M, Nakajima M, et al. Expression of Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma. Eur J Cancer 2004; 40:2804-11.
14. Ho SB, Toribara NW, Bresalier RS, Kim YS. Biochemical and other markers of colon cancer. Gastroenterol Clin North Am 1988; 17:811-36.
15. Baumheter S, Singer MS, Henzel W, et al. Binding of l-selectin to the vascular sialomucin CD34. Science 1993; 262:436-8.
16. Young PE, Baumhueter S, Lasky LA. The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. Blood 1995; 85:96-105.
17. Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997; 385:640-4.
18. Lanza F, Healy L, Sutherland DR. Structural and functional features of the CD34 antigen: an update. J Biol Regul Homeost Agents 2001; 15:1-13.
19. El-Shahat M, Lotfy M, Fahmy L, et al. Prognostic value of microvessel density, matrix metalloproteinase-9 and p53 protein expression in esophageal cancer. J Egypt Natl Cancer Inst 2004; 16:224-30.
20. Igarashi M, Dhar DK, Kubota H, et al. The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer 1998; 82:1225-32.
21. Irimura T, Nakamori S, Matsushita Y, et al. Colorectal cancer metastasis determined by carbohydrate-mediated cell adhesion: role of sialyl-Lex antigens. Semin Cancer Biol 1993; 4:319-24.
22. Kannagi R, Izawa M, Koike T, et al. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 2004; 95:377-84.